Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults

NCT07513168 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Weight Reduction
Cardiometabolic Risk Factors

Interventions

DRUG: Locally available low-dose semaglutide (0.25 mg, 0.5 mg, 1 mg)

Sponsor

Asian Institute Of Medical Sciences